427 related articles for article (PubMed ID: 30419250)
1. Revisiting the association of HLA alleles and haplotypes with CYP21A2 mutations in a large cohort of patients with congenital adrenal hyperplasia.
Jayakrishnan R; Lao Q; Adams SD; Ward WW; Merke DP
Gene; 2019 Mar; 687():30-34. PubMed ID: 30419250
[TBL] [Abstract][Full Text] [Related]
2. A new CYP21A1P/CYP21A2 chimeric gene identified in an Italian woman suffering from classical congenital adrenal hyperplasia form.
Concolino P; Mello E; Minucci A; Giardina E; Zuppi C; Toscano V; Capoluongo E
BMC Med Genet; 2009 Jul; 10():72. PubMed ID: 19624807
[TBL] [Abstract][Full Text] [Related]
3. Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene.
Fanis P; Skordis N; Phylactou LA; Neocleous V
Hormones (Athens); 2023 Mar; 22(1):71-77. PubMed ID: 36264454
[TBL] [Abstract][Full Text] [Related]
4. Congenital adrenal hyperplasia due to two rare CYP21A2 variant alleles, including a novel attenuated CYP21A1P/CYP21A2 chimera.
Lao Q; Burkardt DD; Kollender S; Faucz FR; Merke DP
Mol Genet Genomic Med; 2023 Jul; 11(7):e2195. PubMed ID: 37157918
[TBL] [Abstract][Full Text] [Related]
5. Chimeric CYP21A1P/CYP21A2 genes identified in Czech patients with congenital adrenal hyperplasia.
Vrzalová Z; Hrubá Z; Hrabincová ES; Vrábelová S; Votava F; Koloušková S; Fajkusová L
Eur J Med Genet; 2011; 54(2):112-7. PubMed ID: 20970527
[TBL] [Abstract][Full Text] [Related]
6. Association of HLA alleles and haplotypes with CYP21A2 gene p. V282L mutation in the Croatian population.
Grubic Z; Maskalan M; Stingl Jankovic K; Zvecic S; Dumic Kubat K; Krnic N; Zunec R; Ille J; Kusec V; Dumic M
HLA; 2016 Nov; 88(5):239-244. PubMed ID: 27709802
[TBL] [Abstract][Full Text] [Related]
7. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
[TBL] [Abstract][Full Text] [Related]
8. The Prevalence of the Chimeric TNXA/TNXB Gene and Clinical Symptoms of Ehlers-Danlos Syndrome with 21-Hydroxylase Deficiency.
Gao Y; Lu L; Yu B; Mao J; Wang X; Nie M; Wu X
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32291442
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic study of congenital adrenal hyperplasia in Serbia: novel p.Leu129Pro and p.Ser165Pro CYP21A2 gene mutations.
Milacic I; Barac M; Milenkovic T; Ugrin M; Klaassen K; Skakic A; Jesic M; Joksic I; Mitrovic K; Todorovic S; Vujovic S; Pavlovic S; Stojiljkovic M
J Endocrinol Invest; 2015 Nov; 38(11):1199-210. PubMed ID: 26233337
[TBL] [Abstract][Full Text] [Related]
10. CYP21A2 p.E238 deletion as result of multiple microconversion events: a genetic study on an Italian congenital adrenal hyperplasia (CAH) family.
Concolino P; Mello E; Zuppi C; Toscano V; Capoluongo E
Diagn Mol Pathol; 2013 Mar; 22(1):48-51. PubMed ID: 23370425
[TBL] [Abstract][Full Text] [Related]
11. A rare CYP21A2 haplotype clarifies the phenotype-genotype discrepancy in an Italian patient with Non Classical Congenital Adrenal Hyperplasia (NC-CAH).
Concolino P
Mol Biol Rep; 2020 Apr; 47(4):3049-3052. PubMed ID: 32185686
[TBL] [Abstract][Full Text] [Related]
12. Study of Human Leukocyte Antigen (HLA) in 13 cases of familial frontal fibrosing alopecia: CYP21A2 gene p.V281L mutation from congenital adrenal hyperplasia linked to HLA class I haplotype HLA-A*33:01; B*14:02; C*08:02 as a genetic marker.
Porriño-Bustamante ML; López-Nevot MÁ; Aneiros-Fernández J; Casado-Ruiz J; García-Linares S; Pedrinacci-Rodríguez S; García-Lora E; Martín-Casares MA; Fernández-Pugnaire MA; Arias-Santiago S
Australas J Dermatol; 2019 Aug; 60(3):e195-e200. PubMed ID: 30656636
[TBL] [Abstract][Full Text] [Related]
13. Junction site analysis of chimeric CYP21A1P/CYP21A2 genes in 21-hydroxylase deficiency.
Chen W; Xu Z; Sullivan A; Finkielstain GP; Van Ryzin C; Merke DP; McDonnell NB
Clin Chem; 2012 Feb; 58(2):421-30. PubMed ID: 22156666
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Finkielstain GP; Chen W; Mehta SP; Fujimura FK; Hanna RM; Van Ryzin C; McDonnell NB; Merke DP
J Clin Endocrinol Metab; 2011 Jan; 96(1):E161-72. PubMed ID: 20926536
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of the CYP21A2 gene in Chinese patients with steroid 21-hydroxylase deficiency.
Ma D; Chen Y; Sun Y; Yang B; Cheng J; Huang M; Zhang J; Zhang J; Hu P; Lin Y; Jiang T; Xu Z
Clin Biochem; 2014 Apr; 47(6):455-63. PubMed ID: 24503005
[TBL] [Abstract][Full Text] [Related]
16. Identification of CYP21A2 mutant alleles in Czech patients with 21-hydroxylase deficiency.
Vrzalová Z; Hrubá Z; St'ahlová Hrabincová E; Pouchlá S; Votava F; Kolousková S; Fajkusová L
Int J Mol Med; 2010 Oct; 26(4):595-603. PubMed ID: 20818501
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia.
Dumic KK; Grubic Z; Yuen T; Wilson RC; Kusec V; Barisic I; Stingl K; Sansovic I; Skrabic V; Dumic M; New MI
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):51-56. PubMed ID: 27041116
[TBL] [Abstract][Full Text] [Related]
18. A new CYP21A2 nonsense mutation causing severe 21-hydroxylase deficiency.
Concolino P; Minucci A; Mello E; Zuppi C; Capoluongo E
Clin Chem Lab Med; 2009; 47(7):824-5. PubMed ID: 19499972
[TBL] [Abstract][Full Text] [Related]
19. Ehlers-Danlos Syndrome: Molecular and Clinical Characterization of TNXA/TNXB Chimeras in Congenital Adrenal Hyperplasia.
Marino R; Garrido NP; Ramirez P; Notaristéfano G; Moresco A; Touzon MS; Vaiani E; Finkielstain G; Obregón MG; Balbi V; Soria I; Belgorosky A
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2789-e2802. PubMed ID: 33482002
[TBL] [Abstract][Full Text] [Related]
20. Investigation of CYP21A2 mutations in Turkish patients with 21-hydroxylase deficiency and a novel founder mutation.
Toraman B; Ökten A; Kalay E; Karagüzel G; Dinçer T; Açıkgöz EG; Karagüzel A
Gene; 2013 Jan; 513(1):202-8. PubMed ID: 23142378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
